ArticleTranslational vision science & technology2025
Conjunctival Venular Hemodynamic Biomarkers in Glaucoma.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: Vascular dysfunction is considered a factor contributing to glaucomatous damage. Imaging the bulbar conjunctiva offers a noninvasive approach for directly assessing systemic microcirculation. The purpose of the current study was to test the hypothesis that there is an association between alterations in conjunctival venular hemodynamic biomarkers and presence of primary open-angle glaucoma (POAG). Methods: This cross-sectional study included 26 normal control (NC) and 29 POAG subjects. Conjunctival microcirculation was assessed non-invasively by combining video microscopy and an automated software to measure the following conjunctival venular hemodynamic biomarkers: vessel diameter (D), blood velocity (V), blood flow (Q), wall shear rate (WSR), and wall shear stress (WSS). Results: Age differed between NC and POAG groups (P < 0.001), while other ocular and systemic factors were not significantly different (P ≥ 0.05). Conjunctival venular V, WSR, and WSS were significantly reduced in POAG compared to NC, both with and without adjusting for covariates and accounting for multiple comparisons (adjusted P ≤ 0.03). In the adjusted models, the differences in conjunctival venular D and Q between NC and POAG groups were not significant (P ≥ 0.16). Conclusions: The finding of reduced conjunctival venular wall shear stress in POAG supports the vascular theory of glaucoma, implicating endothelial dysfunction. Conjunctival wall shear stress may serve as a novel biomarker for glaucomatous vascular damage. Translational Relevance: Assessment of microvasculature wall shear stress may serve as a novel biomarker of endothelium function with the potential to improve the understanding, diagnosis and monitoring of glaucoma and other optic neuropathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.